Hexcellence US IPOs Weekly Recap - Week of July 6, 2020
Three biotechnology companies, two Chinese issuers, and one SPAC went public in the week of July 6, 2020, led by preclinical oncology biotech healthcare company, Nkarta (Nasdaq: NKTX), which skyrocketed 166% in its first day of trading.
The two Chinese issuers are BlueCity Holdings (Nasdaq: BLCT) and Quhuo (Nasdaq: QH) which raised $85 million and $33 million respectively.
The first warrantless SPAC in history, Therapeutics Acquisition (Nasdaq: TXAC) rose 20% on its first day of trading, the best record for a SPAC, and continued to finish the week up 58%.
#ipo #nasdaq #nyse #nkarta #therapeuticsacquisition #bluecity #quhuo #poseida #inventiva #capitalmarket #hexcellence
Hexcellence Consulting has experienced IPO consulting team focus on listing in US Stock Market,
namely NYSE, Nasdaq and OTC Markets.
Should you interested to list your company in US Stock Market,
please contact us at [email protected].